A Phase II Study of Sunitinib in Recurrent or Progressive Brain Tumors in Pediatric and Young Adult Patients

Grant

Awarded By

Total Award Amount

  • 20300.00

    • Direct Costs

  • 16111.00

    • Sponsor Award Id

    • Contributor

  • Gregory Friedman M.D.   Investigator